CytoMed Therapeutics Limited Proceeds From Issue Of Ordinary Shares
CytoMed Therapeutics Limited (GDTC) reported Proceeds From Issue Of Ordinary Shares of SGD 283.09 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromIssueOfOrdinaryShares · last filed 2026-03-31
SGD
| Period end | Proceeds From Issue Of Ordinary Shares 12 month |
|---|---|
| 2025-12-31 | 283.09K SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | 11.31M SGD 20-F · filed 2026-03-31 |
| 2022-12-31 | 1.22M SGD 20-F · filed 2025-04-28 |
| 2021-12-31 | 2.00M SGD 20-F · filed 2024-04-22 |
| 2020-12-31 | 500.00K SGD 20-F · filed 2023-05-01 |
USD
| Period end | Proceeds From Issue Of Ordinary Shares 12 month |
|---|---|
| 2025-12-31 | $220.15K 20-F · filed 2026-03-31 |
| 2023-12-31 | $8.57M 20-F · filed 2024-04-22 |
| 2022-12-31 | $912.15K 20-F · filed 2023-05-01 |